Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1966 1
1968 1
1969 4
1970 4
1971 3
1972 2
1973 6
1974 6
1975 9
1976 13
1977 8
1978 6
1979 13
1980 9
1981 8
1982 8
1983 16
1984 14
1985 11
1986 5
1987 15
1988 14
1989 12
1990 17
1991 12
1992 18
1993 8
1994 17
1995 8
1996 11
1997 21
1998 11
1999 13
2000 7
2001 6
2002 11
2003 17
2004 6
2005 13
2006 19
2007 12
2008 12
2009 15
2010 7
2011 10
2012 6
2013 9
2014 12
2015 9
2016 11
2017 5
2018 13
2019 6
2020 8
2021 9
2022 6
2023 11
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

542 results

Results by year

Filters applied: . Clear all
Page 1
Physiology, production and action of progesterone.
Taraborrelli S. Taraborrelli S. Acta Obstet Gynecol Scand. 2015 Nov;94 Suppl 161:8-16. doi: 10.1111/aogs.12771. Acta Obstet Gynecol Scand. 2015. PMID: 26358238 Free article. Review.
RESULTS AND CONCLUSIONS: A better understanding of the biological genomic and non-genomic receptor mechanisms could enable us in the near future to obtain a more comprehensive knowledge of the safety and efficacy of this agent during hormone replacement therapy (natural progester …
RESULTS AND CONCLUSIONS: A better understanding of the biological genomic and non-genomic receptor mechanisms could enable us in the near fu …
Etonogestrel.
[No authors listed] [No authors listed] 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000572 Free Books & Documents. Review.
Etonogestrel is available in the United States in a combination contraceptive vaginal ring (NuvaRing) that releases 120 mcg of etonogestrel and 15 mcg of ethinyl estradiol daily, and subcutaneous implants (Implanon, Nexplanon) that release etonogestrel at a decreasi …
Etonogestrel is available in the United States in a combination contraceptive vaginal ring (NuvaRing) that releases 120 mcg of etonogestrel …
Complications of Subcutaneous Contraception: A Review.
Ramdhan RC, Simonds E, Wilson C, Loukas M, Oskouian RJ, Tubbs RS. Ramdhan RC, et al. Cureus. 2018 Jan 31;10(1):e2132. doi: 10.7759/cureus.2132. Cureus. 2018. PMID: 29610715 Free PMC article. Review.
Over 62 million women in the United States are of childbearing age and 60% of them use contraception. Subcutaneous contraceptives include implantable contraceptives and subcutaneous injections. Implantable contraception involves subdermal time-release …
Over 62 million women in the United States are of childbearing age and 60% of them use contraception. Subcutaneous contraceptives inc …
Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
Moeti DMP, Govender I, Bongongo T. Moeti DMP, et al. S Afr Fam Pract (2004). 2022 Jul 7;64(1):e1-e6. doi: 10.4102/safp.v64i1.5407. S Afr Fam Pract (2004). 2022. PMID: 35924618 Free PMC article.
Fifty-one participants kept the etonogestrel subcutaneous contraceptive implant in for a longer period of 12-23 months. From participants' responses, it seems that Etonogestrel implants may be offered from as early as 15-20 years of age. ...Heavy bleeding was …
Fifty-one participants kept the etonogestrel subcutaneous contraceptive implant in for a longer period of 12-23 months. From p …
[Long-acting reversible contraception].
Raccah-Tebeka B, Plu-Bureau G. Raccah-Tebeka B, et al. Rev Prat. 2018 Apr;68(4):387-391. Rev Prat. 2018. PMID: 30869384 French.
Indeed, these contraceptive methods, including intrauterine devices and the subcutaneous implant, allow obtaining an optimal contraceptive effectiveness while reducing the constraints for the women. ...
Indeed, these contraceptive methods, including intrauterine devices and the subcutaneous implant, allow obtaining an optimal c …
Progestin-only contraception: injectables and implants.
Jacobstein R, Polis CB. Jacobstein R, et al. Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):795-806. doi: 10.1016/j.bpobgyn.2014.05.003. Epub 2014 Jun 5. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24996766 Free article. Review.
Progestin-only contraceptive injectables and implants are highly effective, longer-acting contraceptive methods that can be used by most women in most circumstances. ...Implants have the highest effectiveness of any contraceptive method. Commodity cost, which …
Progestin-only contraceptive injectables and implants are highly effective, longer-acting contraceptive methods that can be us …
Progestogens in luteal support.
Carp HJA. Carp HJA. Horm Mol Biol Clin Investig. 2020 May 22;42(2):143-148. doi: 10.1515/hmbci-2019-0067. Horm Mol Biol Clin Investig. 2020. PMID: 32432564 Review.
Progestational agents are often prescribed to increase the clinical pregnancy rate in assisted reproduction. Progestogens affect implantation, cytokine balance, natural killer cell activity, arachidonic acid release and myometrial contractility. ...This article summarises …
Progestational agents are often prescribed to increase the clinical pregnancy rate in assisted reproduction. Progestogens affect implanta …
Postpartum contraception: A matter of guidelines.
Grandi G, Del Savio MC, Tassi A, Facchinetti F. Grandi G, et al. Int J Gynaecol Obstet. 2024 Jan;164(1):56-65. doi: 10.1002/ijgo.14928. Epub 2023 Jun 19. Int J Gynaecol Obstet. 2024. PMID: 37334892 Review.
Guidelines agree on the prescription of the progestin-only pill postpartum in non-breastfeeding women (category 1). Differences are found in women who breastfeed. In non-breastfeeding women, an implant is considered safe (category 1) by all guidelines, without any d …
Guidelines agree on the prescription of the progestin-only pill postpartum in non-breastfeeding women (category 1). Differences are f …
Contraception today.
Benagiano G, Bastianelli C, Farris M. Benagiano G, et al. Ann N Y Acad Sci. 2006 Dec;1092:1-32. doi: 10.1196/annals.1365.002. Ann N Y Acad Sci. 2006. PMID: 17308130 Review.
A new minipill (progestin-only preparation) containing desogestrel has been recently marketed in a number of countries and is capable of consistently inhibiting ovulation in most women. ...Finally, several subcutaneously implanted systems have been developed: …
A new minipill (progestin-only preparation) containing desogestrel has been recently marketed in a number of countries and is capable …
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction.
Capobianco G, Sanna E, Gulotta A, Virdis G, Dessole F, Maida I, Madonia M, Cudoni F, Petrillo M. Capobianco G, et al. Eur J Contracept Reprod Health Care. 2024 Aug;29(4):171-176. doi: 10.1080/13625187.2024.2354248. Epub 2024 May 24. Eur J Contracept Reprod Health Care. 2024. PMID: 38785129
Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n47) over a 6-year period (2015-2021). We submitted the women a series of questions by telephone questionnaire (range 10-72 months after placements …
Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n47) ov …
542 results